PharmTech LCGC Sciex Webinar 11.10
|Articles|August 15, 2008

Shimadzu and Seegene Announce Partnership

Shimadzu Corporation (Columbia, Maryland) and Seegene, Inc. (Rockville, Maryland) have entered into a partnership in which Seegene's polymerase chain reaction-based Seeplex tests will be combined with Shimadzu's MultiNA high-speed electrophoresis system for multipathogen analysis and detection.

Shimadzu Corporation (Columbia, Maryland) and Seegene, Inc. (Rockville, Maryland) have entered into a partnership in which Seegene's polymerase chain reaction?based Seeplex tests will be combined with Shimadzu's MultiNA high-speed electrophoresis system for multipathogen analysis and detection. The microchip electrophoresis system is designed for DNA and RNA nucleic acid size confirmation and quantification. The multipathogen tests reportedly are capable of detecting multiple pathogens in a single tube and can be used in molecular diagnostics for human, animal, plant, and microorganism applications.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.